Show
Sort by
-
- Journal Article
- A1
- open access
ASAS-EULAR recommendations for the management of axial spondyloarthritis : 2022 update
-
Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’: time to embrace the ASAS-defined nomenclature
-
Inequity in biological DMARD prescription for spondyloarthritis across the globe : results from the ASAS-COMOSPA study
-
Work participation in spondyloarthritis across countries : analysis from the ASAS-COMOSPA study
-
- Journal Article
- A2
- open access
Efficacy and safety of biological and targeted-synthetic DMARDs : a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis
-
- Journal Article
- A2
- open access
Efficacy and safety of non-pharmacological and non-biological pharmacological treatment : a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis
-
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
-
Gender-attributable differences in outcome of ankylosing spondylitis : long-term results from the Outcome in Ankylosing Spondylitis International Study
-
- Journal Article
- A2
- open access
Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis : a longitudinal analysis
-
Hierarchy of impairment of spinal mobility measures in ankylosing spondylitis: twelve-year data
-
Characteristics associated with the presence and development of extra-articular manifestations in ankylosing spondylitis: 12-year results from OASIS
-
Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study
-
Variations in criteria regulating treatment with reimbursed biologic DMARDs across European countries : are differences related to country's wealth?
-
Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort
-
Erosions and sclerosis on radiographs precede the subsequent development of syndesmophytes at the same site: a twelve-year prospective followup of patients with ankylosing spondylitis
-
Inequities in access to biologic and synthetic DMARDs across 46 European countries
-
Aspects of validity of the self-administered comorbidity questionnaire in patients with ankylosing spondylitis
-
How to deal with missing items in BASDAI and BASFI
-
Gender-attributable differences in outcome of ankylosing spondylitis: long-term results from the outcome in ankylosing spondylitis international study
-
Do extra-articular manifestations influence outcome in ankylosing spondylitis?: a 12 year follow-up study